These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24835938)

  • 1. Charge-transfer reaction of 1,4-benzoquinone with crizotinib: spectrophotometric study, computational molecular modeling and use in development of microwell assay for crizotinib.
    Darwish IA; Alshehri JM; Alzoman NZ; Khalil NY; Abdel-Rahman HM
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Oct; 131():347-54. PubMed ID: 24835938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Charge-transfer reaction of 2,3-dichloro-1,4-naphthoquinone with crizotinib: Spectrophotometric study, computational molecular modeling and use in development of microwell assay for crizotinib.
    Alzoman NZ; Alshehri JM; Darwish IA; Khalil NY; Abdel-Rahman HM
    Saudi Pharm J; 2015 Jan; 23(1):75-84. PubMed ID: 25685046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Charge-Transfer Complex of Linifanib with 2,3-dichloro-3,5-dicyano-1,4-benzoquinone: Synthesis, Spectroscopic Characterization, Computational Molecular Modelling and Application in the Development of Novel 96-microwell Spectrophotometric Assay.
    Darwish IA; Khalil NY; Alsaif NA; Herqash RN; Sayed AYA; Abdel-Rahman HM
    Drug Des Devel Ther; 2021; 15():1167-1180. PubMed ID: 33737805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovative use of σ and π electron acceptors in the development of three high throughput 96-microwell spectrophotometric assays for crizotinib.
    Darwish IA; Alzoman NZ; Alshehri JM; Darwish HW; Hamidaddin MA; Sayed AY
    Spectrochim Acta A Mol Biomol Spectrosc; 2021 Oct; 259():119884. PubMed ID: 33971436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrophotometric and computational investigations of charge transfer complexes of chloranilic acid with tyrosine kinase inhibitors and application to development of novel universal 96-microwell assay for their determination in pharmaceutical formulations.
    Darwish IA; Khalil NY; Darwish HW; Alzoman NZ; Al-Hossaini AM
    Spectrochim Acta A Mol Biomol Spectrosc; 2021 May; 252():119482. PubMed ID: 33571740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High throughput microwell spectrophotometric assay for olmesartan medoxomil in tablets based on its charge-transfer reaction with DDQ.
    Darwish IA; Wani TA; Khalil NY; Abdel-Rahman HM
    Acta Pharm; 2014 Mar; 64(1):63-75. PubMed ID: 24670352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Charge Transfer Complex of Lorlatinib with Chloranilic Acid: Characterization and Application to the Development of a Novel 96-Microwell Spectrophotometric Assay with High Throughput.
    Darwish HW; Darwish IA; Ali AM; Almutairi HS
    Molecules; 2023 May; 28(9):. PubMed ID: 37175262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, spectroscopic and computational studies on hydrogen bonded charge transfer complex of duvelisib with chloranilic acid: Application to development of novel 96-microwell spectrophotometric assay.
    Darwish IA; Almehizia AA; Sayed AY; Khalil NY; Alzoman NZ; Darwish HW
    Spectrochim Acta A Mol Biomol Spectrosc; 2022 Jan; 264():120287. PubMed ID: 34455386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel High-Throughput Microwell Spectrophotometric Assay for One-Step Determination of Lorlatinib, a Novel Potent Drug for the Treatment of Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer.
    Al-Hossaini AM; Darwish IA; Darwish HW
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109714
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of Two Novel One-Step and Green Microwell Spectrophotometric Methods for High-Throughput Determination of Ceritinib, a Potent Drug for Treatment of Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer.
    Abuhejail RM; Alzoman NZ; Darwish IA
    Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893531
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel analytical approach for reducing the consumption of organic solvents in the charge transfer-based spectrophotometric analysis: application in the analysis of certain antihypertensive drugs.
    Darwish IA; Mahmoud AM; Al-Majed AR
    Acta Pharm; 2010 Dec; 60(4):493-501. PubMed ID: 21169140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel microwell-based spectrophotometric assay for determination of atorvastatin calcium in its pharmaceutical formulations.
    Wani TA; Khalil NY; Abdel-Rahman HM; Darwish IA
    Chem Cent J; 2011 Oct; 5(1):57. PubMed ID: 21982201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental and Computational Evaluation of Chloranilic Acid as an Universal Chromogenic Reagent for the Development of a Novel 96-Microwell Spectrophotometric Assay for Tyrosine Kinase Inhibitors.
    Darwish IA; Darwish HW; Khalil NY; Sayed AYA
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33572664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel 96-microwell assay with high throughput for determination of olmesartan medoxomil in its tablets.
    Darwish IA; Wani TA; Khalil NY; Al-Shaikh AA; Al-Morshadi N
    Chem Cent J; 2012 Jan; 6():1. PubMed ID: 22214530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrophotometric Study of Charge-Transfer Complexes of Ruxolitinib with Chloranilic Acid and 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone: An Application to the Development of a Green and High-Throughput Microwell Method for Quantification of Ruxolitinib in Its Pharmaceutical Formulations.
    Aljaber KA; Darwish IA; Al-Hossaini AM
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and comparative evaluation of two immunoassay platforms for bioanalysis of crizotinib: A potent drug used for the treatment of non-small cell lung cancer.
    Hamidaddin MA; AlRabiah H; Darwish IA
    Talanta; 2019 Aug; 201():217-225. PubMed ID: 31122414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crizotinib in the management of advanced-stage non-small-cell lung cancer.
    Loong HH; Mok K; Leung LK; Mok TS
    Future Oncol; 2015; 11(5):735-45. PubMed ID: 25757678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crizotinib: a drug that crystallizes a unique molecular subset of non-small-cell lung cancer.
    Ou SH
    Expert Rev Anticancer Ther; 2012 Feb; 12(2):151-62. PubMed ID: 22316363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrophotometric and fluorescence quenching studies of the charge transfer complexation of (4-dimethylamino-benzylidene)-(4,6-dimethyl-pyrimidin-2-yl)-amine with some organic acceptors.
    El-Sayed YS
    Spectrochim Acta A Mol Biomol Spectrosc; 2011 Apr; 78(4):1227-33. PubMed ID: 21300564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crizotinib: an anaplastic lymphoma kinase inhibitor.
    Gadgeel SM; Bepler G
    Future Oncol; 2011 Aug; 7(8):947-53. PubMed ID: 21823889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.